Ontology highlight
ABSTRACT:
SUBMITTER: Koch Hein EC
PROVIDER: S-EPMC10487051 | biostudies-literature | 2023 Aug
REPOSITORIES: biostudies-literature
Koch Hein Erica C EC Vilbert Maysa M Hirsch Ian I Fernando Ribeiro Mauricio M Muniz Thiago P TP Fournier Cynthia C Abdulalem Khaled K Saldanha Erick F EF Martinez Erika E Spreafico Anna A Hogg David H DH Butler Marcus O MO Saibil Samuel D SD
Cancers 20230829 17
Immune checkpoint inhibitors (ICI) cemiplimab and pembrolizumab have revolutionized the treatment of advanced cutaneous squamous cell carcinoma (cSCC). We aimed to evaluate the effectiveness and safety of ICI in a real-world cSCC population, including patients with conditions that would exclude clinical trial participation. In this single-center, retrospective cohort study, we included all non-trial patients with advanced cSCC treated with ICI between 2017 and 2022. We evaluated investigator-ass ...[more]